CONTACT US   |  (864) 397-5101

Ensuring gender inclusivity: A pledge to women’s participation in clinical research

Clemson

Clemson Rural Health signs agreement with Precia Group to bring clinical research opportunities to women in rural and underserved communities. 

Clemson Rural Health (CRH) is pleased to announce its affiliation with Precia Group, a contract research organization (CRO) with a focus on women’s health. In alignment with Clemson University’s new strategic plan, Clemson Elevate, CRH and Precia Group will bring clinical research opportunities to rural communities typically excluded from trials centralized in hospital systems or universities.

Ron Gimbel, professor and director of Clemson Rural Health, said the partnership is a natural fit, as both organizations are deeply committed to improving health outcomes through inclusive and decentralized clinical research practices.

“Since 2019, we have built a strong leadership team and founded a network of rural hub clinics in order to serve as a foundational leader for decentralized clinical trials in our state,” said Gimbel. “Our next step is to join forces with strategically aligned partners, like Precia Group, to accelerate the transformation of health outcomes in rural and underserved communities.” 

Setting itself apart from other CROs, Precia is dedicated to addressing gender bias historically present in clinical trials. Precia is increasing the number of women in research studies by establishing the first-of-its-kind community-based network across the United States and globally, engaging women as partners.

Precia Group’s commitment to inclusive research practices is at the heart of its mission to ensure that more women from diverse backgrounds participate in clinical trials by bringing those trials to the community setting, where most women seek and receive their care. Their goal is for all women to have equal opportunities to engage in research, contribute to the data and generalizable knowledge, and play a pivotal role in shaping and improving medical advancements and treatments.  

“We are thrilled to welcome Clemson Rural Health Network as our first rural health sites within the Precia Network,” said Donna Russell, founder and CEO of Precia Group. “Together, we are addressing the critical need to expand clinical trial access for underserved rural patients who often face significant health disparities. This partnership between Clemson Rural Health Research Network and Precia Group is committed to ensuring that rural communities are given an opportunity to actively participate in the advancement of medical treatments tailored to their unique needs.” 

About Precia Group 

Headquartered in Seattle, Precia Group is a Contract Research Organization (CRO) established in 2020. Its mission is to accelerate equity in research, improve the quality of research data and ultimately improve patient outcomes by dramatically increasing the number of underrepresented communities and populations in clinical trials.  

About Clemson Rural Health 

Clemson Rural Health is a part of the College of Behavioral, Social and Health Sciences, a 21st-century land-grant college joining together a unique combination of schools and departments: communication, nursing, parks, recreation and tourism management, political science, psychology, public health sciences and sociology, anthropology and criminal justice. These areas have distinctive characteristics and missions – all joined together by a common thread of service to people and communities. For more information, visit ClemsonRuralHealth.org.  

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.